Ablynx extends Nanobody collaboration with Boehringer; More action on the Russian VC front;

 @FierceBiotech: Cytos revives lead program in $40M financing deal with Amgen, venBio. News | Follow @FierceBiotech

 @JohnCFierce: NicOx (France) takes an option to buy Altacor in the U.K., with an eye to building an ophthalmology company. Release | Follow @JohnCFierce

 @RyanMFierce: Hepatera, a Russian biotech, has grabbed a mystery amount of funding for a hepatitis program. Release | Follow @RyanMFierce

@FierceMedDev: Stryker Stent May Not Be Worth the Stroke Risks, FDA Says via @BloombergNews. Story | Follow @FierceMedDev

> The Belgian biotech Ablynx ($ABLX) has inked a two-year extension to its collaboration with German drugmaker Boehringer Ingelheim to advance up to 10 Nanobody drugs, providing Ablynx with an additional 6.6 million euros. Release

> Recently formed Russian biotech Hepatera and its German partner MYR have raised an undisclosed amount of funding from Moscow-based Maxwell Biotech Venture Fund and venture firm High-Tech Gründerfonds of Germany. Release

> UCB Pharma has committed £3.6 million ($5.7 million) over the next three years in its collaboration with Oxford University to research drugs in immunology and neurology. Report

Pharma News

 @FiercePharma: Pfizer to pay $3.3M to settle Zyvox probe. Story | Follow @FiercePharma

> Teva to jump to NYSE. News

> Targacept management acknowledges layoffs are possible. More

> Pharma sales execs: Current model is broken; changes are coming. Article

> Sandoz: We won't hike prices in Canada during shortage. Story

> FDA panel backs GSK's Votrient for soft-tissue sarcoma. News

Biomarkers News

> There may be more to mesothelioma than mesothelin. Item

> RNA could predict cancer recurrence risk. Article

> Triple-negative breast cancer biomarker points to new cancer model. More

> Study: Alzheimer's not prevented by antioxidants. Story

Drug Delivery News

> Bend Research, in nod to Pfizer, eyes biotherapeutics drug delivery. Story

> Echo Therapeutics reports $16.7M loss after Prelude delay. More

> U.K. CF gene therapy trials to test inhaled and viral delivery options. Article

Medical Device News

> Olympus confronts scandal with 3 new surgical devices. News

> U.S. Supreme Court KOs Prometheus Labs' test patent suit. More

> Genoptix test to guide melanoma treatment decisions. Story

> J&J lawsuit bombshell: Company marketed vaginal mesh minus FDA nod. Article

And Finally… In favor of biologics, a gap between the numbers of patents filed for biotech drugs versus those for small molecules is growing. Item

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.